Amino acid-modified PAMAM dendritic nanocarriers as effective chemotherapeutic drug vehicles in cancer treatment: a study using zebrafish as a cancer model. Issue 35 (1st June 2020)

• Record Type: Journal Article
• Authors: Wu, Szu-Yuan; Chou, Hsiao-Ying; Tsai, Hsieh-Chih; Anbazhagan, Rajeshkumar; Yuh, Chiou-Hwa; Yang, Jen Ming; Chang, Yen-Hsiang
• Is Part Of: RSC advances. Volume 10:Issue 35(2020)
• Page Start: 20682
• Page End: 20690
• Publication Date: 2020-06-01
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d0ra01589j
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : The use of nanomaterials for drug delivery offers many advantages including the controlled release and their targeted delivery. Abstract : The use of nanomaterials for drug delivery offers many advantages including the targeted delivery of drugs and their controlled release. Nonetheless, entry into the target cells remains a challenge for many nanomaterials used for drug delivery. Moreover, cellular uptake limits the therapeutic efficiency of many anticancer drugs. An important goal is to increase the specific accumulation of these nanoparticles (NPs) at the desired cancerous tissues. Notably, cancer cells show a high demand for some amino acids and we have used this knowledge to develop novel carrier systems. In this study, drug carriers were produced by the conjugation of multiple amino acids such as l -histidine (H) and l -cysteine (C) or single amino acids such as only H with the G4.5 dendrimers (G) to produce GHC aggregates and GH NP carriers, respectively. Doxorubicin was loaded into the G4.5, GH, and GHC dendrimers (G/DOX, GH/DOX and GHC/DOX, respectively) and the release mechanism was demonstrated at pH 7.4 and pH 5.0. GH/DOX and GHC/DOX showed better stability under physiological conditions than the dendrimer alone (G/DOX). GH/DOX and GHC/DOX exhibited higher inhibition of HeLa cell proliferation in in vitro and in vivo studies in zebrafish, confirming the early release of DOX by disrupting the endosomal membrane and triggering the destabilization of carriers at a lower pH of 5.0.